D. Sucunza

发表

Gene therapy approaches in the non-human primate model of Parkinson’s disease

J. Lanciego, Kazuto Kobayashi, S. Kato, 2018, Journal of Neural Transmission.

Adeno-Associated Viral Vectors Serotype 8 for Cell-Specific Delivery of Therapeutic Genes in the Central Nervous System

J. Lanciego, G. González-Aseguinolaza, Á. Vales, 2017, Front. Neuroanat..

Amyloid-Driven Tau Accumulation on Mitochondria Potentially Leads to Cognitive Deterioration in Alzheimer’s Disease

R. Luján, J. Fernández-Irigoyen, E. Santamaría, 2021, International journal of molecular sciences.

Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death

J. Lanciego, J. Kulisevsky, D. Sucunza, 2018, Neurotherapeutics.

PLA2G4E, a candidate gene for resilience in Alzheimer´s disease and a new target for dementia treatment

R. Luján, M. Pérez-González, María Espelosin, 2020, Progress in Neurobiology.

Calbindin content and differential vulnerability of midbrain efferent dopaminergic neurons in macaques

J. Lanciego, D. Pignataro, D. Sucunza, 2014, Front. Neuroanat..

Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death

J. Lanciego, J. Kulisevsky, D. Sucunza, 2018, Neurotherapeutics.

Glucocerebrosidase expression patterns in the non-human primate brain

J. Lanciego, D. Pignataro, D. Sucunza, 2017, Brain Structure and Function.

Neurochemical evidence supporting dopamine D1–D2 receptor heteromers in the striatum of the long-tailed macaque: changes following dopaminergic manipulation

J. Lanciego, R. Franco, S. George, 2016, Brain Structure and Function.

Glucocerebrosidase Gene Therapy Induces Alpha-Synuclein Clearance and Neuroprotection of Midbrain Dopaminergic Neurons in Mice and Macaques

J. Lanciego, V. Broccoli, G. González-Aseguinolaza, 2021, International journal of molecular sciences.